Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
0.9583
-0.0351 (-3.53%)
At close: May 8, 2025, 4:00 PM
0.9700
+0.0117 (1.22%)
After-hours: May 8, 2025, 4:49 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Site-specific and Novel-format Antibody Drug Conjugates
153.73M
Log In
Log In
Log In
Log In
Upgrade
Site-specific and Novel-format Antibody Drug Conjugates Growth
126.84%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
153.73M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
126.84%
Log In
Log In
Log In
Log In
Upgrade